Cargando…
Prophylactic Phenylephrine Increases the Dose Requirement of Oxytocin to Treat Uterine Atony During Cesarean Delivery: A Double-Blinded, Single-Center, Randomized and Placebo-Controlled Trial
Purpose: Studies involving mouse models and human uterine smooth muscle cells have shown that phenylephrine inhibits uterine contractions in non-pregnant mice and human in vitro cell via cyclic adenosine monophosphate (cAMP) signaling. However, there has been no limited exploration to date of the ef...
Autores principales: | Shen, Yao-Hua, Yang, Fan, Jin, Li-Dan, Qian, Yu-Jia, Xing, Li, Huang, Ya-Li, Lin, Su-Feng, Xiao, Fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563700/ https://www.ncbi.nlm.nih.gov/pubmed/34744714 http://dx.doi.org/10.3389/fphar.2021.720906 |
Ejemplares similares
-
The optimal oxytocin infusion rate for preventing uterine atony during cesarean delivery in elderly parturients with prior history of cesarean delivery
por: Wang, Li Ying, et al.
Publicado: (2023) -
Prophylactic Dose of Oxytocin for Uterine Atony during Caesarean Delivery: A Systematic Review
por: Baliuliene, Vilda, et al.
Publicado: (2021) -
The Median Effective Dose of Oxytocin Needed to Prevent Uterine Atony During Cesarean Delivery in Elderly Parturients
por: Wei, Chang Na, et al.
Publicado: (2020) -
Clinical outcomes of prophylactic compression sutures for treatment of uterine atony during the cesarean delivery of twins
por: Kim, Mi-La, et al.
Publicado: (2020) -
Uterus Wrapping: A Novel Concept in the Management of Uterine Atony during Cesarean Delivery
por: Kimmich, N., et al.
Publicado: (2015)